Free Trial
CVE:IBT

IBEX Technologies (IBT) Stock Price, News & Analysis

C$1.44
0.00 (0.00%)
(As of 04/5/2024)

About IBEX Technologies Stock (CVE:IBT)

Key Stats

Today's Range
C$1.44
C$1.44
50-Day Range
C$1.44
C$1.44
52-Week Range
C$0.75
C$1.45
Volume
200 shs
Average Volume
68,888 shs
Market Capitalization
C$35.29 million
P/E Ratio
9.60
Dividend Yield
3.11%
Price Target
N/A
Consensus Rating
N/A

Company Overview

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

ibex Launches Wave iX Translate
A new way to play the AI boom (act before November 19)
There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as little as $16 and a brokerage account.
IBEX Completes Sale of the Company
IBEX Technologies Inc.
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

IBEX Technologies' stock was trading at C$1.19 at the beginning of the year. Since then, IBT stock has increased by 21.0% and is now trading at C$1.44.
View the best growth stocks for 2024 here
.

Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE) and Bank of Montreal (BMO).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$3.98 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$8 million
Cash Flow
C$0.92 per share
Book Value
C$0.58 per share

Miscellaneous

Free Float
N/A
Market Cap
C$35.29 million
Optionable
Not Optionable
Beta
-0.05
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (CVE:IBT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners